Chronic lymphocytic leukaemia: open trials in Switzerland

• NCT04728893

  Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

  Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC

  Istituto Oncologica della Svizzera Italiana (IOSI) (Site 2302), Bellinzona · Inselspital Bern (Site 2303), Bern

  Registry updated 2026-10-27

• NCT03342144

  Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting

  Research · AbbVie

  Kantonsspital Aarau AG /ID# 210034, Aarau · EOC Ospedale Regionale di Bellinzona e Valli /ID# 208782, Bellinzona · Inselspital, Universitaetsspital Bern /ID# 210031, Bern · Luzerner Kantonsspital /ID# 210029, Lucerne · Kantonsspital Münsterlingen /ID# 210035, Münsterlingen · Réseau Hospitalier Neuchâtelois /ID# 227865, Neuchâtel · Kantonsspital St. Gallen /ID# 223037, Sankt Gallen · Spital Thun /ID# 233714, Thun · KSW Kantonsspital Winterthur /ID# 211068, Winterthur

  Registry updated 2026-10-21

• NCT06973187

  A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  Trial Treatment · Phase 3 · BeOne Medicines

  Inselspital Bern (Inselspital, Universitatsspital Bern), Bern · Universitätsspital Zürich, Zurich

  Registry updated 2026-09-28

• NCT05131022

  A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  Trial Treatment · Phase 1 · Nurix Therapeutics, Inc.

  Universitätsspital Basel, Basel · Istituto Oncologico della Svizzera Italiana, Bellinzona · Inselspital - Universitatsklinik Bern, Bern · Hôpitaux universitaires de Genève, Geneva · Kantonsspital St. Gallen, Sankt Gallen · University Hospital Zurich, Zurich

  Registry updated 2026-07-02

• NCT06357754

  Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

  Research · Bristol-Myers Squibb

  Kantonsspital Aarau, Aarau

  Registry updated 2026-01-22

• NCT07166549

  Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)

  Trial Treatment · Phase 1 · University Hospital, Basel, Switzerland

  University Hospital Basel, Division of Hematology or Medical Oncology, Basel

  Registry updated 2025-12-24

• NCT04502394

  Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

  Trial Treatment · Phase 1/2 · Kartos Therapeutics, Inc.

  Kantonsspital St. Gallen, Sankt Gallen

  Registry updated 2022-08-04

All Chronic lymphocytic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error